These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29962407)

  • 61. Using Peptide Aptamer Targeted Polymers as a Model Nanomedicine for Investigating Drug Distribution in Cancer Nanotheranostics.
    Zhao Y; Houston ZH; Simpson JD; Chen L; Fletcher NL; Fuchs AV; Blakey I; Thurecht KJ
    Mol Pharm; 2017 Oct; 14(10):3539-3549. PubMed ID: 28880092
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A novel DDS strategy, "dual-targeting", and its application for antineovascular therapy.
    Murase Y; Asai T; Katanasaka Y; Sugiyama T; Shimizu K; Maeda N; Oku N
    Cancer Lett; 2010 Jan; 287(2):165-71. PubMed ID: 19616372
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Multifunctional Envelope-Type Nano Device: Evolution from Nonselective to Active Targeting System.
    Hayashi Y; Hatakeyama H; Kajimoto K; Hyodo M; Akita H; Harashima H
    Bioconjug Chem; 2015 Jul; 26(7):1266-76. PubMed ID: 25938819
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Microfluidic self-assembly of a combinatorial library of single- and dual-ligand liposomes for in vitro and in vivo tumor targeting.
    Ran R; Wang H; Liu Y; Hui Y; Sun Q; Seth A; Wibowo D; Chen D; Zhao CX
    Eur J Pharm Biopharm; 2018 Sep; 130():1-10. PubMed ID: 29908938
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer.
    Deshpande P; Jhaveri A; Pattni B; Biswas S; Torchilin V
    Drug Deliv; 2018 Nov; 25(1):517-532. PubMed ID: 29433357
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A targeting drug delivery system for ovarian carcinoma: transferrin modified lipid coated paclitaxel-loaded nanoparticles.
    Li R; Zhang Q; Wang XY; Chen XG; He YX; Yang WY; Yang X
    Drug Res (Stuttg); 2014 Oct; 64(10):541-7. PubMed ID: 24443309
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Improved tumor-targeting drug delivery and therapeutic efficacy by cationic liposome modified with truncated bFGF peptide.
    Chen X; Wang X; Wang Y; Yang L; Hu J; Xiao W; Fu A; Cai L; Li X; Ye X; Liu Y; Wu W; Shao X; Mao Y; Wei Y; Chen L
    J Control Release; 2010 Jul; 145(1):17-25. PubMed ID: 20307599
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Factors Influencing the Immunogenicity and Immunotoxicity of Cyclic RGD Peptide-Modified Nanodrug Delivery Systems.
    Wang X; Meng N; Wang S; Lu L; Wang H; Zhan C; Burgess DJ; Lu W
    Mol Pharm; 2020 Sep; 17(9):3281-3290. PubMed ID: 32786957
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hyaluronic acid modified pH-sensitive liposomes for targeted intracellular delivery of doxorubicin.
    Paliwal SR; Paliwal R; Agrawal GP; Vyas SP
    J Liposome Res; 2016 Dec; 26(4):276-87. PubMed ID: 26784587
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Enhanced in vivo antitumor efficacy of dual-functional peptide-modified docetaxel nanoparticles through tumor targeting and Hsp90 inhibition.
    Jiang Y; Yang N; Zhang H; Sun B; Hou C; Ji C; Zheng J; Liu Y; Zuo P
    J Control Release; 2016 Jan; 221():26-36. PubMed ID: 26643616
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Delta-like ligand 4-targeted nanomedicine for antiangiogenic cancer therapy.
    Liu YR; Guan YY; Luan X; Lu Q; Wang C; Liu HJ; Gao YG; Yang SC; Dong X; Chen HZ; Fang C
    Biomaterials; 2015 Feb; 42():161-71. PubMed ID: 25542804
    [TBL] [Abstract][Full Text] [Related]  

  • 72. RGD-modified polymeric micelles as potential carriers for targeted delivery to integrin-overexpressing tumor vasculature and tumor cells.
    Wang Y; Wang X; Zhang Y; Yang S; Wang J; Zhang X; Zhang Q
    J Drug Target; 2009 Jul; 17(6):459-67. PubMed ID: 19527117
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Glioma-homing peptide with a cell-penetrating effect for targeting delivery with enhanced glioma localization, penetration and suppression of glioma growth.
    Gao H; Yang Z; Zhang S; Cao S; Pang Z; Yang X; Jiang X
    J Control Release; 2013 Dec; 172(3):921-8. PubMed ID: 24120853
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Novel peptides functionally targeting in vivo human lung cancer discovered by in vivo peptide displayed phage screening.
    Lee KJ; Lee JH; Chung HK; Choi J; Park J; Park SS; Ju EJ; Park J; Shin SH; Park HJ; Ko EJ; Suh N; Kim I; Hwang JJ; Song SY; Jeong SY; Choi EK
    Amino Acids; 2015 Feb; 47(2):281-9. PubMed ID: 25366491
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Design of Multifunctional Liposomal Nanocarriers for Folate Receptor-Specific Intracellular Drug Delivery.
    Kang MH; Yoo HJ; Kwon YH; Yoon HY; Lee SG; Kim SR; Yeom DW; Kang MJ; Choi YW
    Mol Pharm; 2015 Dec; 12(12):4200-13. PubMed ID: 26544061
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Dual-Functional Liposomes with Carbonic Anhydrase IX Antibody and BR2 Peptide Modification Effectively Improve Intracellular Delivery of Cantharidin to Treat Orthotopic Hepatocellular Carcinoma Mice.
    Zhang X; Lin C; Chan W; Liu K; Lu A; Lin G; Hu R; Shi H; Zhang H; Yang Z
    Molecules; 2019 Sep; 24(18):. PubMed ID: 31547459
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Active tumor targeting of nanomaterials using folic acid, transferrin and integrin receptors.
    Kolhatkar R; Lote A; Khambati H
    Curr Drug Discov Technol; 2011 Sep; 8(3):197-206. PubMed ID: 21696360
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Towards clinical translation of ligand-functionalized liposomes in targeted cancer therapy: Challenges and opportunities.
    Belfiore L; Saunders DN; Ranson M; Thurecht KJ; Storm G; Vine KL
    J Control Release; 2018 May; 277():1-13. PubMed ID: 29501721
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Tandem Peptide Based on Structural Modification of Poly-Arginine for Enhancing Tumor Targeting Efficiency and Therapeutic Effect.
    Liu Y; Lu Z; Mei L; Yu Q; Tai X; Wang Y; Shi K; Zhang Z; He Q
    ACS Appl Mater Interfaces; 2017 Jan; 9(3):2083-2092. PubMed ID: 28025892
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Thioaptamer conjugated liposomes for tumor vasculature targeting.
    Mann AP; Bhavane RC; Somasunderam A; Liz Montalvo-Ortiz B; Ghaghada KB; Volk D; Nieves-Alicea R; Suh KS; Ferrari M; Annapragada A; Gorenstein DG; Tanaka T
    Oncotarget; 2011 Apr; 2(4):298-304. PubMed ID: 21666286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.